RXRX

NASDAQStock$3.63-0.03 (-0.68%)
Mkt Cap 1.9BP/E —Div Yield —Beta 1.03Vol 16.7M
52W$2.84
$6.30

ETFs That Hold RXRX (Recursion Pharmaceuticals, Inc.)

1M

-10.12%

3M

+22.97%

6M

+4.60%

YTD

-13.33%

1Y

-36.70%

3Y

-36.14%

5Y

-80.07%

ETFs That Hold RXRX

Recursion Pharmaceuticals, Inc. is held by 86 ETFs. The largest position by market value is in ARKG (ARK Genomic Revolution ETF).

ETFFund NameWeight
ITDBiShares LifePath Target Date 2030 ETF0.00%
IRTRiShares LifePath Retirement ETF0.00%
ISCBiShares Morningstar Small-Cap ETF0.03%
JKJiShares Morningstar Small-Cap ETF0.03%
MSMLiShares MSCI USA Small-Cap ETF0.03%
IWNiShares Russell 2000 Value ETF0.01%

Excludes leveraged and inverse ETFs.

PreviousPage 5 of 5

Frequently Asked Questions

How many ETFs hold RXRX?
Recursion Pharmaceuticals, Inc. (RXRX) is held by 86 ETFs (excluding leveraged and inverse funds). The largest position by market value is in ARKG (ARK Genomic Revolution ETF).
What is the largest ETF that holds RXRX?
By fund size, ARKG (ARK Genomic Revolution ETF) with $2.22B in AUM holds 3.13% of its portfolio in RXRX, representing $125.9M in market value.
Is RXRX in the S&P 500?
RXRX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.